The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...

Glioblastoma, one of the most aggressive and lethal brain cancers, has a five-year survival rate of only 6.9%, according to the National Brain Tumor Society. While the relationship between ...

“Understanding how the repertoire of immune cells fits with the diverse landscape of brain cancer types can help us find new ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC). The research identified enolase 2 (ENO2), a ...

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

The Kingdom of Jordan recently opened its first advanced nuclear medicine diagnostic centre in a public hospital with IAEA support, significantly increasing access to diagnostic services for cancer ...

Brain and spinal cord ... atypical teratoid/rhabdoid tumor, and aggressive glioma, including glioblastoma and recurrent pilocytic astrocytoma. He developed one of a handful of diffuse intrinsic ...

Science fiction can be valuable in the broader communication ecosystem, bringing science to the public and offering scientists a space to exercise imagination.